Healthy participants
Conditions
Interventions
12 weeks intake of the test food 1
12 weeks intake of the placebo food
Sponsors
ITO EN, LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese men and women aged 20 years or more at the time of informed consent 2) Participants who is able to take 9 capsules daily for 2 weeks. 3) Non smoker 4) Participants who has received sufficient explanation of the purpose and content of the research, is capable of giving informed consent, voluntarily volunteers to participate in the research, and consents to participate in the research in writing.
Exclusion criteria
Exclusion criteria: 1) Participants who is currently receiving any medications or outpatient treatment. 2) Participants who is currently doing exercise or diet under the supervision of a doctor 3) Participants who is may develop allergy due to the test food 4) Participants who is drug dependent, present or dependent on alcohol 5) Participantst who is history of psychiatry during hospitalization due to mental disorder (depression etc.) or sleep disorder (insomnia, sleep apnea syndrome etc.) 6)Night shift or shift workers 7) Excessively irregular lifestyle such as eating or sleeping 8) Participants who is extreme skipped eating 9) Participants who is current disease or history of diabetes, liver disease (hepatitis), kidney disease, serious disease such as heart disease, thyroid disease, adrenal disease, other metabolic diseases 10) Participants who is use health foods, supplements, and medicines that may affect cognitive function 11) Participants who is participated in other human clinical studies within the past 3 months or are expected to participate in other human clinical studies during the study period. 12) Participants who is pregnant, breast-feeding, or willing to become pregnant during the study period 13) Participants who is difficult to comply with the records of various surveys 14) Participants who is judged to be unsuitable as subject from clinical laboratory test value and measurement value at the time of SCR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| perception of Emotions test (correct response, reaction time) Electroencephalography | — |
Secondary
| Measure | Time frame |
|---|---|
| Shifting attention test (correct response, errors, reaction time) | — |
Countries
Japan
Contacts
Public ContactYoshitake Baba
ITO EN, LTD. Central Research Institute
Outcome results
None listed